Farmanews.com

Notas de Prensa  

Salud. 28 de agosto de 2019
Eit health spain headstart awards 2019

EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign

EIT Health Spain has announced the 15 Spanish start-ups selected for 2019 Headstart Programe, which includes funding, mentoring and networking opportunities. Among those selected are Senolytic Therapeutics and Moirai Biodesign based in the Barcelona Science Park. 

Selected companies will work on their product launch project with support from the regional managers to access local market (Photo: EIT Health).

 

Senolytic Therapeutics and Morai Biodesign, headquartered in the Barcelona Science Park, are two of the 15 awarded Spanish start-ups in the 2019 EIT Health Headstart Programme to accelerate their time-to-market, that includes funding, mentoring and networking opportunities.

Moirai Biodesign is a biotech start-up that develops Kloto-DX, a near-patient, end-to-end, low-cost and fast molecular diagnostics platform. This next generation diagnostic tool is built upon their Plug and Play RNA technology, a family of programmable biosensors capable of detecting low concentrations of different biomarkers from a patient’s blood sample. The first kit they are developing for the Kloto-DX diagnostics platform is focused at the determination of the aetiology of sepsis. The kit will allow identification of the most important sepsis-causing pathogens and their associated antibiotic resistances, at the point of care and directly from the patient's blood, in just three hours.

Senolytic Therapeutics develops novel classes of medicines that target and eliminate damaged (senescent) cells. Their mission is to advance a portfolio of therapies to clinical trials and improve the lives of those affected by diseases associated with ageing. They have developed a unique technological portfolio that is based on drug therapies that eliminate senescent in age-related diseases. The development of therapies to specifically inhibit PD-L2 in damaged cells results in the improvement in the outcomes of diseases associated with these types of cells.,

“We are delighted to support these early stage companies in their journey to develop global health solutions,” said Irene Sánchez, Business Creation Manager at EIT Health Spain. “The high quality of the applications received this year clearly shows that innovative and entrepreneurship culture are firmly rooted and speeding up in Spain.”

The EIT Health Headstart Programme provides funding of up to €50 000 to support early stage companies and SMEs in developing new products and services. Selected companies will work on their product launch project with support from the regional managers to access local and EIT Health networks. The programme seeks to help entrepreneurs shorten time-to-market for innovative products and services; to verify the need and/or benefit of the solution for users, customers, payers, and partners; and to increase the possibility of attracting further investment.

The three areas of the innovation triangle: research, education and business creation

EIT Health Spain is the Spanish node of EIT Health, the Knowledge and Innovation Community (KIC), dedicated to healthy living and active aging and promoted by the European Institute of Technology and Innovation (EIT). Based in the Barcelona Science Park (PCB), the consortium currently brings together 18 leading public and private entities in the three areas of the innovation triangle: research, education and business creation.

Since 2016, EIT Health supported more than 100 Spanish start-ups through a variety of acceleration programmes designed to support healthcare entrepreneurs at every stage of their business journey. Only in 2019, EIT Health will contribute more than €1 million to the Spanish health entrepreneurship ecosystem.

More information: EIT Health Spain website [+]

Subir  

Subir notas de prensa y convocatorias

Próximas convocatorias   


Ver todas

Especialidades  

Busca notas de prensa por especialidad médica o enfermedad.



Ver todas

Archivo  

Busca notas de prensa por su fecha de edición.

  Selecciona el año


Copyright © 2019, Farmavet, S.L. Todos los derechos reservados.